The purpose of this study is to verify the efficacy and safety of the Liquid Embolic System (Tonbridge Medical Tech. Co., Ltd. (Suzhou)) for the treatment of cerebrovascular malformations.
Age 18 to 80 years, any gender;
Subject is suitable for endovascular treatment of cerebrovascular malformations;
Subject is able to understand the purpose of the study, shows sufficient compliance with the study protocol and provides a signed informed consent form.
Intracranial hemorrhage within 1 month prior to treatment;
The targeted embolization area needs to receive other treatments (surgical resection, SRS, other embolic materials) at the same time;
Combination of other cerebrovascular malformations, such as cavernous vascular malformation;
Severe stenosis or occlusion of cerebral feeding artery requiring surgical intervention;